Introduction: No study has yet assessed the utility of biochemical biomarkers for evaluating NET burden using 68Ga-DOTATATE PET/CT.
Aim(s): To determine which markers are associated with total NET burden.
Materials and methods: A retrospective analysis of a prospective database of patients with NETs (n=232). Fasting plasma chromogranin A (CgA), neuron-specific enolase (NSE), gastrin, glucagon, vasoactive intestinal peptide (VIP) and pancreatic polypeptide (PP), and 24-hour urinary 5-hydroxyindoleacetic acid (5HIAA) levels were measured.
Conference: 14th Annual ENETS conference 2017 (2017)
Presenting Author: MD Amit Tirosh
, Papadakis G Z
, Millo C
, Sadowski S M
, Herscovitch P
, Pacak K
, Marx S J
, Yang L
, Nockel P
, Shell J
, Green P
, Keutgen X M
, Patel D
, Nilubol N
, Kebebew E
To read results and conclusion, please login ...
Further abstracts you may be interested in